Capricor Therapeutics (CAPR) Times Interest Earned (2013 - 2017)
Capricor Therapeutics (CAPR) recorded quarterly Times Interest Earned of -$40.85 in Q4 2017, down 66.71% quarter-over-quarter from -$24.5 in Q3 2017, and down 44.29% on a YoY basis from -$73.32 in Q4 2016.
Capricor Therapeutics (CAPR) Times Interest Earned (2013 - 2017) Analysis & Trends
Capricor Therapeutics' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$40.85 for Q4 2017.
- In Q4 2017, Times Interest Earned fell 44.29% year-over-year to -$40.85; the TTM figure through Sep 2018 stood at -$190.54 (down 542.59% YoY), while the FY2025 annual figure was -$35.51, changed N/A from the prior year.
- Times Interest Earned was -$40.85 for Q4 2017 at Capricor Therapeutics, down from -$24.5 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$24.5 in Q3 2017 to a low of -$385.96 in Q1 2013.
- Historically, Times Interest Earned has averaged -$73.68 across 5 years, with a median of -$48.22 in 2014.
- The sharpest annual moves came in 2014 and 2015: Times Interest Earned soared 89.59% in 2014, then plunged 87.0% in 2015.
- A 5-year view of Times Interest Earned shows it stood at -$94.99 in 2013, then soared by 67.46% to -$30.91 in 2014, then tumbled by 67.14% to -$51.66 in 2015, then surged by 45.2% to -$28.31 in 2016, then tumbled by 44.29% to -$40.85 in 2017.
- The last three Times Interest Earned figures came in at -$40.85 (Q4 2017), -$24.5 (Q3 2017), and -$32.02 (Q2 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -40.85 |
| Sep 30, 2017 | -24.50 |
| Jun 30, 2017 | -32.02 |
| Mar 31, 2017 | -33.85 |
| Dec 31, 2016 | -28.31 |
| Sep 30, 2016 | -53.06 |
| Jun 30, 2016 | -59.99 |
| Mar 31, 2016 | -63.68 |
| Dec 31, 2015 | -51.66 |
| Sep 30, 2015 | -46.21 |
| Jun 30, 2015 | -49.64 |
| Mar 31, 2015 | -55.36 |
| Dec 31, 2014 | -30.91 |
| Sep 30, 2014 | -24.71 |
| Jun 30, 2014 | -27.06 |
| Mar 31, 2014 | -46.81 |
| Dec 31, 2013 | -94.99 |
| Sep 30, 2013 | -63.98 |
| Jun 30, 2013 | -260.04 |
| Mar 31, 2013 | -385.96 |